Search results
From Proteopedia
You searched for Fulvestrant
There is no page with the exact title "Fulvestrant". The search results for "Fulvestrant" are displayed below. You can create a page titled Fulvestrant (by clicking on the red link).
For more information about searching Proteopedia, see Help.
Showing below 19 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Fulvestrant (42 bytes)
1: List of pages with the keyword Fulvestrant
Page text matches
- 4j03 (3,645 bytes)
2: ...of human soluble epoxide hydrolase complexed with fulvestrant==
14: ...s was tested for inhibition of sEH. We found that fulvestrant, an anticancer agent, is a potent (KI=26nM) compe...
16: Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.,Morisseau C, Pakhomova S, Hwang S... - Category:Fulvestrant (42 bytes)
1: List of pages with the keyword Fulvestrant - 8tdu (8,166 bytes)
16: ...n observed with alpelisib. Combining STX-478 with fulvestrant and/or cyclin-dependent kinase 4/6 inhibitors was... - 6chw (6,554 bytes)
14: ...and ERa(Y537S) breast cancer that was superior to fulvestrant. Lastly, H3B-5942 potency can be further improved... - 6p05 (4,361 bytes)
16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen... - Epoxide hydrolase 3D structures (6,177 bytes)
83: **[[4j03]] – hSEH + fulvestrant<br /> - 6sbo (6,299 bytes)
14: ...t cancer following antiestrogen therapy. However, fulvestrant shows poor pharmacokinetic properties in human, l... - 6wok (6,087 bytes)
14: ...-class" molecule with the same dual mechanisms as fulvestrant, but with significant oral exposure. Through lead... - 6zoq (6,046 bytes)
14: ...at showed a pharmacological profile comparable to fulvestrant in its ability to degrade ERalpha in both MCF-7 a... - 6zor (6,025 bytes)
14: ...at showed a pharmacological profile comparable to fulvestrant in its ability to degrade ERalpha in both MCF-7 a... - 6zos (6,039 bytes)
14: ...at showed a pharmacological profile comparable to fulvestrant in its ability to degrade ERalpha in both MCF-7 a... - 7jkw (4,219 bytes)
16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen... - 7jky (4,272 bytes)
16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen... - 7jkz (4,328 bytes)
16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen... - 7te7 (6,234 bytes)
14: ...tor degrader fulvestrant. This advance shows that fulvestrant-like genomic activities can be achieved without a...
16: Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cance... - 8duk (6,362 bytes)
14: ...tor degrader fulvestrant. This advance shows that fulvestrant-like genomic activities can be achieved without a...
16: Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cance... - 8tgd (8,229 bytes)
16: ...n observed with alpelisib. Combining STX-478 with fulvestrant and/or cyclin-dependent kinase 4/6 inhibitors was... - 8xoi (4,112 bytes)
2: ... of GPR30-Gq complex structure in the presence of fulvestrant==
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
